Brian N. C. Prichard

673 total citations
18 papers, 542 citations indexed

About

Brian N. C. Prichard is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Brian N. C. Prichard has authored 18 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 5 papers in Pharmacology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Brian N. C. Prichard's work include Pharmacology and Obesity Treatment (5 papers), Hormonal Regulation and Hypertension (5 papers) and Blood Pressure and Hypertension Studies (4 papers). Brian N. C. Prichard is often cited by papers focused on Pharmacology and Obesity Treatment (5 papers), Hormonal Regulation and Hypertension (5 papers) and Blood Pressure and Hypertension Studies (4 papers). Brian N. C. Prichard collaborates with scholars based in United Kingdom, Belgium and Malta. Brian N. C. Prichard's co-authors include Brian Tomlinson, Luís M. Ruilope, C.A. Saxton, W. S. Singleton, Donald S. Davies, François Bompart, Stephen J. Davies, Christopher C. H. Cook, Christopher Smith and Michael B. Cooper and has published in prestigious journals such as The American Journal of Cardiology, Drugs and Journal of Hypertension.

In The Last Decade

Brian N. C. Prichard

18 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian N. C. Prichard United Kingdom 13 272 112 85 67 64 18 542
B. E. Karlberg Sweden 16 286 1.1× 199 1.8× 79 0.9× 71 1.1× 106 1.7× 52 677
Michael Davidov United States 19 505 1.9× 119 1.1× 174 2.0× 72 1.1× 77 1.2× 44 872
BN Prichard United Kingdom 12 150 0.6× 47 0.4× 84 1.0× 59 0.9× 69 1.1× 17 380
Giudicelli Jf France 12 256 0.9× 56 0.5× 66 0.8× 87 1.3× 122 1.9× 77 543
Kwan E. Kim United States 12 247 0.9× 66 0.6× 105 1.2× 41 0.6× 100 1.6× 18 737
WH Aellig Japan 9 202 0.7× 65 0.6× 115 1.4× 114 1.7× 66 1.0× 10 452
Peter C. Rubin United Kingdom 16 258 0.9× 89 0.8× 90 1.1× 78 1.2× 94 1.5× 48 868
Louis Wj Australia 14 150 0.6× 74 0.7× 103 1.2× 76 1.1× 133 2.1× 29 547
F. J. Zacharias United Kingdom 9 601 2.2× 155 1.4× 145 1.7× 62 0.9× 49 0.8× 14 866
T. O. Morgan Australia 10 211 0.8× 66 0.6× 45 0.5× 60 0.9× 50 0.8× 26 461

Countries citing papers authored by Brian N. C. Prichard

Since Specialization
Citations

This map shows the geographic impact of Brian N. C. Prichard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian N. C. Prichard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian N. C. Prichard more than expected).

Fields of papers citing papers by Brian N. C. Prichard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian N. C. Prichard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian N. C. Prichard. The network helps show where Brian N. C. Prichard may publish in the future.

Co-authorship network of co-authors of Brian N. C. Prichard

This figure shows the co-authorship network connecting the top 25 collaborators of Brian N. C. Prichard. A scholar is included among the top collaborators of Brian N. C. Prichard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian N. C. Prichard. Brian N. C. Prichard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Smith, Christopher, Brian N. C. Prichard, & Michael B. Cooper. (2009). Platelet α- and β-secretase activities: A preliminary study in normal human subjects. Platelets. 20(1). 29–34. 7 indexed citations
2.
Prichard, Brian N. C., et al.. (2002). Placebo-controlled Comparison of the Efficacy and Tolerability of Once-daily Moxonidine and Enalapril in Mild to Moderate Essential Hypertension. Blood Pressure. 11(3). 166–172. 18 indexed citations
3.
Ruilope, Luís M., et al.. (2001). Eprosartan versus Enalapril in Elderly Patients with Hypertension: a Doubleblind, Randomized Trial. Blood Pressure. 10(4). 223–229. 40 indexed citations
4.
Prichard, Brian N. C., et al.. (2000). I1 Imidazoline Agonists. General Clinical Pharmacology of Imidazoline Receptors. Drugs & Aging. 17(2). 133–159. 12 indexed citations
5.
Prichard, Brian N. C., et al.. (1997). The use of moxonidine in the treatment of hypertension. Journal of Hypertension. 15(1). S47–S55. 24 indexed citations
6.
Cook, Christopher C. H., et al.. (1991). TRACE ELEMENT AND VITAMIN DEFICIENCY IN ALCOHOLIC AND CONTROL SUBJECTS. Alcohol and Alcoholism. 26(5-6). 541–548. 21 indexed citations
7.
Tomlinson, Brian, et al.. (1989). Effects of noradrenaline infusion on platelet catecholamine levels and platelet aggregation. Journal of Hypertension. 7(6). S166–167. 4 indexed citations
8.
Prichard, Brian N. C., et al.. (1989). Urapidil, a multiple-action alpha-blocking drug. The American Journal of Cardiology. 64(7). D11–D15. 19 indexed citations
9.
Tomlinson, Brian, et al.. (1989). A log-dose-response study of xipamide and its effect on metabolic parameters. Journal of Hypertension. 7(6). S320–321. 2 indexed citations
11.
Prichard, Brian N. C., et al.. (1988). Clinical pharmacology of urapidil. Journal of Hypertension. 6(Sup 2). S13???20–S13???20. 5 indexed citations
12.
Bühler, Fritz R., Hans R. Brunner, Lennart Hansson, et al.. (1986). Introduction Position of Beta Blockers in Antihypertensive Therapy. Journal of Cardiovascular Pharmacology. 8(Supplement 6). S1–S4. 2 indexed citations
13.
Singleton, W. S., et al.. (1982). Postjunctional Selectivity of α-Blockade with Prazosin, Trimazosin, and UK-33,274 in Man. Journal of Cardiovascular Pharmacology. 4. S145–S151. 41 indexed citations
14.
Prichard, Brian N. C.. (1977). Beta-adrenoceptor blocking drugs.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 219(1312). 501–8. 21 indexed citations
15.
Davies, Donald S. & Brian N. C. Prichard. (1973). Biological effects of drugs in relation to their plasma concentrations : proceedings of a symposium held by the British Pharmacological Society at the Royal Postrgraduate Medical School, London, on January 4, 1972. Macmillan eBooks. 14 indexed citations
16.
Prichard, Brian N. C., et al.. (1966). Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma. The American Journal of Cardiology. 18(3). 394–398. 78 indexed citations
17.
Prichard, Brian N. C., et al.. (1966). Propranolol in the therapy of angina pectoris. The American Journal of Cardiology. 18(3). 366–369. 83 indexed citations
18.
Prichard, Brian N. C., et al.. (1966). Propranolol in hypertension. The American Journal of Cardiology. 18(3). 387–391. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026